Synergy in Diseases and Therapy
About the Journal
Editor-in-Chief: Da Johan Cae (view profile)
Abbreviated Key Title: Synergy DT
ISSN (online): 2-8
Published by: Synergy Publishers
Periodicity: One volume per year – Open Access
Contact: info@synergypublishers.com
Indexed in:
EZB Nutzeranfragen, Google Scholar, DAIJ, DRJI, WorldCat, OA-Library, Open J-Gate, Knowledge Hub: Virtual Library, Scientific World Index, Science Library Index, Eurasian Scientific Journal Index (ESJI), Scientific Indexing Services
Aims & Scope
“Synergy JD is a peer-reviewed, translational medical journal dedicated to unraveling disease pathogenesis, etiology, and innovative therapies. We bridge molecular mechanisms, clinical insights, and cutting-edge treatments to advance precision medicine for human pathologies—from bench to bedside.”
Core Themes
Disease Etiology & Pathogenesis
Risk Factors and Epidemiology of Human Diseases
Molecular/cellular mechanisms (e.g., inflammation, fibrosis, neurodegeneration).
Genetic, epigenetic, and environmental triggers of disease.
Human Pathologies
Focus on oncology, metabolic, infectious, autoimmune, and rare diseases.
Comparative pathology (animal models vs. human clinical data).
Treatment Strategies & Therapeutics
Drug repurposing, combination therapies, and adverse effect management.
Pharmacogenomics and personalized treatment algorithms.
Targeted Therapy & Precision Medicine
Biomarker-driven therapies (e.g., monoclonal antibodies, CAR-T cells).
AI/ML for patient stratification and drug response prediction.
Emerging Therapeutic Modalities
Gene editing (CRISPR), RNA therapeutics, and microbiome interventions.
Nanomedicine and smart drug delivery systems.
Journal Sections
Original Research (Epidemiology, Mechanistic/Clinical studies)
Reviews (Disease-specific deep dives)
Case Reports (Rare/atypical disease presentations)
Clinical Trials (Design, outcomes, and biomarker analyses)
Commentaries (Ethics, healthcare policy, and global disease burdens)
